ici 170809 has been researched along with thromboxane a2 in 2 studies
| Studies (ici 170809) | Trials (ici 170809) | Recent Studies (post-2010) (ici 170809) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 14 | 1 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coker, SJ; Shaw, LA | 1 |
| Batey, AJ; Coker, SJ; Shaw, LA | 1 |
2 other study(ies) available for ici 170809 and thromboxane a2
| Article | Year |
|---|---|
Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists.
Topics: Animals; Arrhythmias, Cardiac; Dioxanes; Drug Combinations; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Quinolines; Rats; Rats, Wistar; Serotonin Antagonists; Thromboxane A2 | 1996 |
Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Pressure; Dioxanes; Electrocardiography; Heart; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinolines; Rats; Rats, Wistar; Refractory Period, Electrophysiological; Serotonin Antagonists; Thromboxane A2; Vasoconstrictor Agents | 1997 |